Lu S - Search Results

1

Application of area scaling analysis to identify natural killer cell and monocyte involvement in the GranToxiLux antibody dependent cell-mediated cytotoxicity assay.

Pollara J, Orlandi C, Beck C, Edwards RW, Hu Y, Liu S, Wang S, Koup RA, Denny TN, Lu S, Tomaras GD, DeVico A, Lewis GK, Ferrari G. Pollara J, et al. Among authors: lu s. Cytometry A. 2018 Apr;93(4):436-447. doi: 10.1002/cyto.a.23348. Epub 2018 Mar 2. Cytometry A. 2018. PMID: 29498807 Free PMC article. Clinical Trial.

2

Immune responses and protection obtained with rotavirus VP6 DNA vaccines given by intramuscular injection.

Yang K, Wang S, Chang KO, Lu S, Saif LJ, Greenberg HB, Brinker JP, Herrmann JE. Yang K, et al. Among authors: lu s. Vaccine. 2001 Apr 30;19(23-24):3285-91. doi: 10.1016/s0264-410x(00)00543-0. Vaccine. 2001. PMID: 11312027

3

Delivery of DNA to skin by particle bombardment.

Wang S, Joshi S, Lu S. Wang S, et al. Among authors: lu s. Methods Mol Biol. 2004;245:185-96. doi: 10.1385/1-59259-649-5:185. Methods Mol Biol. 2004. PMID: 14707379 No abstract available.

4

Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gp120 glycoprotein by codon optimization and C3d fusion in a mouse model.

Liu F, Mboudjeka I, Shen S, Chou TH, Wang S, Ross TM, Lu S. Liu F, et al. Among authors: lu s. Vaccine. 2004 Apr 16;22(13-14):1764-72. doi: 10.1016/j.vaccine.2003.09.054. Vaccine. 2004. PMID: 15068860

5

[Immunogenicity of new DNA vaccine encoding for hepatitis B virus core antigen].

Xing YP, Huang ZH, Wang SX, Cai J, Li J, Lu S. Xing YP, et al. Among authors: lu s. Zhonghua Gan Zang Bing Za Zhi. 2004 Jun;12(6):338-40. Zhonghua Gan Zang Bing Za Zhi. 2004. PMID: 15225426 Chinese.

6

Assays for the assessment of neutralizing antibody activities against Severe Acute Respiratory Syndrome (SARS) associated coronavirus (SCV).

Wang S, Sakhatskyy P, Chou TH, Lu S. Wang S, et al. Among authors: lu s. J Immunol Methods. 2005 Jun;301(1-2):21-30. doi: 10.1016/j.jim.2005.03.008. Epub 2005 Apr 25. J Immunol Methods. 2005. PMID: 15894326 Free PMC article.

7

Enhanced immunogenicity of gp120 protein when combined with recombinant DNA priming to generate antibodies that neutralize the JR-FL primary isolate of human immunodeficiency virus type 1.

Wang S, Arthos J, Lawrence JM, Van Ryk D, Mboudjeka I, Shen S, Chou TH, Montefiori DC, Lu S. Wang S, et al. Among authors: lu s. J Virol. 2005 Jun;79(12):7933-7. doi: 10.1128/JVI.79.12.7933-7937.2005. J Virol. 2005. PMID: 15919951 Free PMC article.

8

Increased immunogenicity of human immunodeficiency virus gp120 engineered to express Galalpha1-3Galbeta1-4GlcNAc-R epitopes.

Abdel-Motal U, Wang S, Lu S, Wigglesworth K, Galili U. Abdel-Motal U, et al. Among authors: lu s. J Virol. 2006 Jul;80(14):6943-51. doi: 10.1128/JVI.00310-06. J Virol. 2006. PMID: 16809300 Free PMC article.

9

Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen.

Sakhatskyy P, Wang S, Chou TH, Lu S. Sakhatskyy P, et al. Among authors: lu s. Virology. 2006 Nov 25;355(2):164-74. doi: 10.1016/j.virol.2006.07.017. Epub 2006 Aug 21. Virology. 2006. PMID: 16919703 Free PMC article.

10

Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines.

Wang S, Taaffe J, Parker C, Solórzano A, Cao H, García-Sastre A, Lu S. Wang S, et al. Among authors: lu s. J Virol. 2006 Dec;80(23):11628-37. doi: 10.1128/JVI.01065-06. Epub 2006 Sep 20. J Virol. 2006. PMID: 16987975 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,183 results

Search Page

Filters